UCLA investigators have developed a new artificial intelligence-based platform that could help scientists identify promising drug combinations to overcome treatment resistance in cancer.

Rakovina has advanced the program from target specification through lead generation and five cycles of iterative lead optimization in approximately two years, using Variational AI’s Enki™ generative ...

More than 41 million people are living with HIV worldwide, and approximately 570,000 died from AIDS-related illnesses in 2025 ...

A preclinical review identifies Ayurvedic phytochemicals as possible multi-target antibiotic adjuncts that could disrupt ...

UCLA investigators have developed a new artificial intelligence-based platform that could help scientists identify promising drug combinations to ...